Daniele Oberti
About Daniele Oberti
Daniele Oberti is a Senior Manager of Clinical Operations at BeiGene with extensive experience in clinical operations and biomedical research.
Company
Daniele Oberti currently works at BeiGene as a Senior Manager in Clinical Operations. BeiGene is a global biotechnology company specializing in the development and commercialization of innovative cancer treatments. Within this role, Oberti is responsible for overseeing key aspects of clinical trial management and ensuring compliance with regulatory standards.
Title
Daniele Oberti holds the title of Senior Manager, Clinical Operations at BeiGene. In this capacity, he brings extensive experience and leadership to the clinical operations team, leveraging his expertise to enhance the efficiency and effectiveness of clinical trial processes.
Education and Expertise
Daniele Oberti earned his PhD in Neuroscience from ETH Zurich, where he also completed a Master in Natural Science with a specialization in Neuroscience. His academic background provides a strong foundation in biomedical research, which he applies to his work in clinical operations. Oberti's expertise includes managing complex clinical trials and conducting in-depth research in neuroscience.
Background
Oberti's professional journey includes significant roles in both academic and clinical research settings. He served as a Postdoctoral Researcher at the Friedrich Miescher Institute for Biomedical Research for five years, contributing to pivotal biomedical studies. Additionally, he worked as a Research Associate at the Brain Research Institute, University of Zurich and ETH Zurich, where he was actively involved in neuroscience research.
Achievements
Throughout his career, Daniele Oberti has managed numerous clinical trials and research projects, particularly in oncology. At SAKK Swiss Group for Clinical Cancer Research, he held roles as Clinical Project Manager I and II, overseeing cancer-related clinical trials. His work in various managerial capacities at BeiGene underscores his adeptness in leading clinical operations and ensuring the success of clinical studies.